Madrigal Pharmaceuticals(MDGL)
$427.39+2.18 (+0.51%)
MDGL
Madrigal Pharmaceuticals earnings date
$427.39
At close:+2.18 (+0.51%)
Want to see MDGL full AI Analyst Report?
Madrigal Pharmaceuticals (MDGL) Q2 2019 Earnings Report
1,368 Followers
MDGL Q2 2019 EPS Results
- Actual EPS
- -$1.28
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.45
MDGL Q2 2019 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/07/2019
- Time
- TBA
- Conference Call
- Wednesday, August 7, 2019
MDGL Upcoming Earnings
Madrigal Pharmaceuticals's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
MDGL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | 1.43- | -2.57 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.861.83 | -5.08 | 136.02% (+6.91) | |
| Jul 30, 2026 | 2026 (Q2) | -2.68-1.99 | -1.9 | -4.74% (-0.09) | |
| May 06, 2026 | 2026 (Q1) | -4.23-3.25 | -3.32 | 2.11% (+0.07) | |
| Feb 19, 2026 | 2025 (Q4) | -0.90-2.57 | -2.71 | 5.17% (+0.14) | |
| Nov 04, 2025 | 2025 (Q3) | -2.29-5.08 | -4.92 | -3.25% (-0.16) | |
| Aug 05, 2025 | 2025 (Q2) | -3.55-1.90 | -7.1 | 73.24% (+5.20) | |
| May 01, 2025 | 2025 (Q1) | -3.75-3.32 | -7.38 | 55.01% (+4.06) | |
| Feb 26, 2025 | 2024 (Q4) | -3.92-2.71 | -5.68 | 52.29% (+2.97) | |
| Oct 31, 2024 | 2024 (Q3) | -6.75-4.92 | -5.34 | 7.87% (+0.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
